ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Fisher Address Gap Between Clinicians Investigators, A Threat To Patient Welfare

May 28, 1993

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992

Oncology Unit – How To Plan, Start It

February 10, 1978

Anti-Estrogen Drug Therapy Reduces Risk of Invasive Breast Cancer In Older Women

July 25, 2008

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

ODAC Oks Melphalan Injection WR-2721 Needs More Data

February 7, 1992